ArticleInfectious Disease Modelling2022
Switched forced SEIRDV compartmental models to monitor COVID-19 spread and immunization in Italy.
Article in Infectious Disease Modelling, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
7 citing papers in PubMed.
- Overcoming bias in estimating epidemiological parameters with realistic history-dependent disease spread dynamics.Nature communications · 2024Article
- Article
- Fitting Early Phases of the COVID-19 Outbreak: A Comparison of the Performances of Used Models.Healthcare (Basel, Switzerland) · 2023Article
- An extended SEIRDV compartmental model: case studies of the spread of COVID-19 and vaccination in Tunisia and South Africa.Annals of medicine and surgery (2012) · 2023Article
- A deterministic compartmental model for the transition between variants in the spread of Covid-19 in Italy.PloS one · 2023Article
- All-People-Test-Based Methods for COVID-19 Infectious Disease Dynamics Simulation Model: Towards Citywide COVID Testing.International journal of environmental research and public health · 2022Article
- Vaccination and variants: Retrospective model for the evolution of Covid-19 in Italy.PloS one · 2022Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
This paper presents a new hybrid compartmental model for studying the COVID-19 epidemic evolution in Italy since the beginning of the vaccination campaign started on 2020/12/27 and shows forecasts of the epidemic evolution in Italy in the first six months. The proposed compartmental model subdivides the population into six compartments and extends the SEIRD model proposed in [E.L.Piccolomini and F.Zama, PLOS ONE, 15(8):1-17, 08 2020] by adding the vaccinated population and framing the global model as a hybrid-switched dynamical system. Aiming to represent the quantities that characterize the epidemic behaviour from an accurate fit to the observed data, we partition the observation time interval into sub-intervals. The model parameters change according to a switching rule depending on the data behaviour and the infection rate continuity condition. In particular, we study the representation of the infection rate both as linear and exponential piecewise continuous functions. We choose the length of sub-intervals balancing the data fit with the model complexity through the Bayesian Information Criterion. We tested the model on italian data and on local data from Emilia-Romagna region. The calibration of the model shows an excellent representation of the epidemic behaviour in both cases. Thirty days forecasts have proven to well reproduce the infection spread, better for regional than for national data. Both models produce accurate predictions of infected, but the exponential-based one perform better in most of the cases. Finally, we discuss different possible forecast scenarios obtained by simulating an increased vaccination rate.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.